Insiders · Profile

BEST LAWRENCE C

Director at HAEMONETICS · Director at MYRIAD GENETICS · EVP and CFO at Boston Scientific. Filing since 16 Jun 2006. CIK 0001191248

Company
Date
Role
Action
Shares
Amount
Of holding
12 Jun 2014
Director
Sold, plan not stated
9,184
$311.44K
47.9%
3 May 2013
Director
Sold, plan not stated
12,000
$459.83K
59.0%
7 Feb 2011
Director
Sold, plan not stated
16,695
$1.03M
88.4%
4 Feb 2011
Director
Sold, plan not stated
15,305
$934.55K
87.4%
1 Dec 2010
Director
Sold, plan not stated
65,000
$1.40M
39.4%
30 Nov 2010
Director
Sold, plan not stated
25,000
$537.21K
13.2%
18 Feb 2010
Director
Sold, plan not stated
100,000
$5.34M
99.0%
17 Feb 2010
Director
Sold, plan not stated
50,000
$2.68M
49.5%
16 Feb 2010
Director
Sold, plan not stated
50,000
$2.68M
39.7%
3 May 2007
EVP and CFO
Sold, plan not stated
300,000
$4.88M
56.4%
2 May 2007
EVP and CFO
Sold, plan not stated
300,000
$4.85M
56.4%
16 Jun 2006
Director
Bought
100,000
$4.66M
opened
12 decisions on file.